Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer
Open Access
- 1 September 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (9) , e0161991
Abstract
Investigation of CF800, a novel PEGylated nano-liposomal imaging agent containing indocyanine green (ICG) and iohexol, for real-time near infrared (NIR) fluorescence and computed tomography (CT) image-guided surgery in an orthotopic lung cancer model in nude mice. CF800 was intravenously administered into 13 mice bearing the H460 orthotopic human lung cancer. At 48 h post-injection (peak imaging agent accumulation time point), ex vivo NIR and CT imaging was performed. A clinical NIR imaging system (SPY®, Novadaq) was used to measure fluorescence intensity of tumor and lung. Tumor-to-background-ratios (TBR) were calculated in inflated and deflated states. The mean Hounsfield unit (HU) of lung tumor was quantified using the CT data set and a semi-automated threshold-based method. Histological evaluation using H&E, the macrophage marker F4/80 and the endothelial cell marker CD31, was performed, and compared to the liposomal fluorescence signal obtained from adjacent tissue sections The fluorescence TBR measured when the lung is in the inflated state (2.0 ± 0.58) was significantly greater than in the deflated state (1.42 ± 0.380 (n = 7, p<0.003). Mean fluorescent signal in tumor was highly variable across samples, (49.0 ± 18.8 AU). CT image analysis revealed greater contrast enhancement in lung tumors (a mean increase of 110 ± 57 HU) when CF800 is administered compared to the no contrast enhanced tumors (p = 0.0002). Preliminary data suggests that the high fluorescence TBR and CT tumor contrast enhancement provided by CF800 may have clinical utility in localization of lung cancer during CT and NIR image-guided surgery.Keywords
This publication has 25 references indexed in Scilit:
- Is telomerase a viable target in cancer?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomesJournal of Controlled Release, 2011
- Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resectionCell Cycle, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Liposome contrast agent for CT‐based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG‐PET and histologyContrast Media & Molecular Imaging, 2010
- In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigationProceedings of the National Academy of Sciences, 2009
- Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor ModelMolecular Pharmaceutics, 2009
- Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal ModelsCancer Research, 2006